title: Pancreatic neuroendocrine tumors.
authors: Digestive Diseases Section, Yale University School of Medicine, New Haven, CT, USA.
authors: Thiruvengadam
authors: T
authors: Muniraj
authors: Sabitha
authors: S
authors: Vignesh
authors: Shilpa
authors: S
authors: Shetty
authors: Sudha
authors: S
authors: Thiruvengadam
authors: Harry R
authors: HR
authors: Aslanian
mesh_terms: D020533:Angiogenesis Inhibitors / Q000627:therapeutic use; D014408:Biomarkers, Tumor; D017115:Catheter Ablation; D003452:Cryosurgery; D003952:Diagnostic Imaging; D004621:Embolization, Therapeutic; D006499:Hepatic Artery; D006801:Humans; D016031:Liver Transplantation; D018761:Multiple Endocrine Neoplasia Type 1 / Q000473:pathology / Q000628:therapy; D020360:Neoadjuvant Therapy; D060787:Neoplasm Grading; D009367:Neoplasm Staging; D018358:Neuroendocrine Tumors / Q000175:diagnosis* / Q000453:epidemiology / Q000628:therapy*; D010180:Pancreatectomy; D010190:Pancreatic Neoplasms / Q000175:diagnosis* / Q000453:epidemiology / Q000628:therapy*; D016577:Pancreaticoduodenectomy; D011379:Prognosis; D011868:Radioisotopes / Q000627:therapeutic use; D018000:Receptors, Peptide / Q000378:metabolism; D040262:Receptors, Vascular Endothelial Growth Factor / Q000037:antagonists & inhibitors; D013004:Somatostatin / Q000031:analogs & derivatives; D058570:TOR Serine-Threonine Kinases / Q000037:antagonists & inhibitors; D014944:World Health Organization
chemical_list: D020533:Angiogenesis Inhibitors; D014408:Biomarkers, Tumor; D011868:Radioisotopes; D018000:Receptors, Peptide; D013004:Somatostatin; D040262:Receptors, Vascular Endothelial Growth Factor; D058570:TOR Serine-Threonine Kinases; C081788:pentetreotide